The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Coen Stacy Ann since 2023.
This trader's CIK number is 1814150.
At the time of last reporting, Coen Stacy Ann was the SVP & CHIEF BUSINESS OFFICER of Immunogen, Inc.. (stock ticker symbol IMGN).
Also see all insider trading activities at Immunogen, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | IMGN | 0 | $0 | 4,583 | $134,281 | 44,350 | $159,600 |
| 2023 | IMGN | 0 | $0 | 297,226 | $4,723,317 | 319,406 | $1,793,935 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-02-02 | IMGN | Option Ex | 14,350 | .00 | 0 |
| 2024-02-05 | IMGN | Sale | 4,583 | 29.30 | 134,281 |
| 2023-12-29 | IMGN | Option Ex | 30,000 | 5.32 | 159,600 |
| 2023-11-30 | IMGN | Sale | 3,826 | 29.20 | 111,719 |
| 2023-11-17 | IMGN | Sale | 78,223 | 16.05 | 1,255,479 |
| 2023-11-15 | IMGN | Option Ex | 26,286 | 6.30 | 165,733 |
| 2023-11-16 | IMGN | Option Ex | 4,100 | 6.30 | 25,850 |
| 2023-11-15 | IMGN | Sale | 26,286 | 16.01 | 420,838 |
| 2023-11-17 | IMGN | Option Ex | 78,223 | 6.30 | 493,196 |
| 2023-11-16 | IMGN | Sale | 4,100 | 16.01 | 65,641 |
| 2023-09-08 | IMGN | Option Ex | 26,006 | 7.69 | 199,986 |
| 2023-08-09 | IMGN | Option Ex | 100,210 | 4.92 | 493,033 |
| 2023-08-09 | IMGN | Sale | 100,210 | 14.20 | 1,422,982 |
| 2023-08-02 | IMGN | Option Ex | 4,255 | 4.92 | 20,934 |
| 2023-08-02 | IMGN | Sale | 4,255 | 18.12 | 77,100 |
| 2023-08-04 | IMGN | Option Ex | 80,326 | 4.92 | 395,203 |
| 2023-08-04 | IMGN | Sale | 80,326 | 17.05 | 1,369,558 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Coen Stacy Ann (SVP & CHIEF BUSINESS OFFICER of Immunogen, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.